ftInvstr
SURAKSHA · Healthcare ₹332.1 -2.44% Mkt Cap ₹1732 Cr

SURAKSHA

Healthcare Diagnostics & Research
₹332.1
-2.44% today · 30d +33.16%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SURAKSHA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹88 Cr
+20.75% YoY
NET PROFIT
₹13 Cr
+40.0% YoY
OPM
35.53%
+1.98pp YoY
EPS
₹2.5
PE 49.26
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-48.5%, h2=-46.4%, h3=-50.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SURAKSHA49.2618.0
SAILIFE93.1518.42
LALPATHLAB62.2931.74
SYNGENE72.0416.59
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
71
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation FAIR 40
Growth STEADY 64
Profitability HIGH 85
Technicals STRONG 70
Risk LOW 90
Key Stats
TTM PE
49.26
P/B
7.18
52W HIGH
₹348.95
OFF HIGH
-4.83%
DIV YIELD
0.15%
MKT CAP
₹1732 Cr
◉ Active Signals
MACDBullish0.5992
RSI(14)Bullish64.27
Near 52W HighBullish-4.83
Street Consensus
1 analyst
₹350.0
mean target
Low ₹350.0Now ₹332.1High ₹350.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SURAKSHA and at what entry.

Sign up freeSign in